Lynn Gold
General Counsel at IPI LEGACY LIQUIDATION CO
Profile
Lynn Gold is currently the Senior Vice President-Regulatory Affairs at Impel Pharmaceuticals, Inc. Prior to this, she worked as the Vice President-Research & Process Development at Sonus Pharmaceuticals, Inc. and as the Vice President-CMC Services at Camargo Pharmaceutical Services LLC.
Dr. Gold holds a doctorate degree from the University of Rochester and an undergraduate degree from the State University of New York at Buffalo.
Lynn Gold active positions
Companies | Position | Start |
---|---|---|
IPI LEGACY LIQUIDATION CO | General Counsel | 2018-06-30 |
Former positions of Lynn Gold
Companies | Position | End |
---|---|---|
Camargo Pharmaceutical Services LLC
Camargo Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Camargo Pharmaceutical Services LLC provides contract drug development, formulation, testing and regulatory consulting services. The company was founded by Kenneth V. Phelps and Ruth E. Stevens in 2003 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | 2010-05-31 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Chief Tech/Sci/R&D Officer | - |
Training of Lynn Gold
Rochester Christian University | Doctorate Degree |
State University of New York at Buffalo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IPI LEGACY LIQUIDATION CO | Health Technology |
Private companies | 2 |
---|---|
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Health Technology |
Camargo Pharmaceutical Services LLC
Camargo Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Camargo Pharmaceutical Services LLC provides contract drug development, formulation, testing and regulatory consulting services. The company was founded by Kenneth V. Phelps and Ruth E. Stevens in 2003 and is headquartered in Cincinnati, OH. | Commercial Services |
- Stock Market
- Insiders
- Lynn Gold